Insider Holders & Insider Ownership - INCYTE CORP (INCY)

List of insiders holdings for INCYTE CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
BAKER BROS. ADVISORS LP
14159 L.P.
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner		2023-03-15 16:09:5436,641,462
0		36,641,462Form 13D
Baker Bros. Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner		2017-02-22 16:47:0134,389,438
0		34,389,438Form 13D
Baker / Tisch Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner		2017-02-22 16:47:0134,389,438
0		34,389,438Form 13D
Baker Biotech Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner		2017-02-22 16:47:0134,389,438
0		34,389,438Form 13D
Baker Brothers Life Sciences Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner		2017-02-22 16:47:0134,389,438
0		34,389,438Form 13D
14159 capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner		2017-02-22 16:47:0134,389,438
0		34,389,438Form 13D
BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner		2024-04-01 16:26:24559,963
33,481,391		34,041,354Form 4
BAKER BIOTECH CAPITAL II GP LLC
BAKER FELIX
BAKER JULIAN
10% Owner		2009-03-02 17:05:3618,593,196
0		18,593,196Form 13D
TISCH ANDREW H
No longer 10% owner.		2005-02-10 11:31:031,541,669
0		1,541,669Form 13G
TISCH THOMAS J
No longer 10% owner.		2004-08-13 15:58:35117,592
1,416,661		1,534,253Form 4/A
TISCH JAMES S
No longer 10% owner.		2004-08-13 15:58:06117,592
1,216,661		1,334,253Form 4/A
TISCH DANIEL R
No longer 10% owner.		2006-04-21 12:04:181,126,669
0		1,126,669Form 13G
WHITFIELD ROY A
Director		2014-01-17 16:19:51662,832
0		662,832Form 5
Hoppenot Herve
Chairman / CEO		2024-02-16 12:50:32502,333
0		502,333Form 4
FRIEDMAN PAUL A
Director		2020-05-28 16:27:11267,327
15,000		282,327Form 4
BROOKE PAUL A
Director		2020-04-02 17:01:14221,911
40,000		261,911Form 4
HASTINGS DAVID C
Chief Financial Officer		2014-06-06 18:47:53227,470
0		227,470Form 4
Wenqing Yao
EVP, Head of Discovery Chem		2021-07-07 17:54:42113,629
0		113,629Form 4
KELLER JOHN A
Chief Business Officer		2008-02-11 17:28:56100,000
0		100,000Form 4
Andrews Patricia S
Chief Commercial Officer		2012-01-23 16:43:17100,000
0		100,000Form 4
DE SCHUTTER RICHARD U
Chairman		2015-03-09 16:35:2199,821
0		99,821Form 4
Stein Steven H
EVP & Chief Medical Officer		2024-02-16 12:49:3397,595
0		97,595Form 4
Pasquale Maria E
EVP & General Counsel		2023-07-18 16:00:1589,999
0		89,999Form 4
Stamoulis Christiana
EVP & Chief Financial Officer		2024-02-16 12:49:0189,983
0		89,983Form 4
Flannelly Barry P
EVP & General Manager US		2024-02-16 12:47:2985,080
0		85,080Form 4
SWAIN PAULA J
EVP, Human Resources		2024-02-16 12:50:0084,907
0		84,907Form 4
SAXE JON S
Director		2004-04-01 14:08:0580,000
0		80,000Form 4
Dhanak Dashyant
EVP & Chief Scientific Officer		2023-07-18 16:00:1875,864
0		75,864Form 4
Morrissey Michael James
EVP, Head of Tech. Operations		2024-01-24 14:15:1372,300
0		72,300Form 4
Daly James M
EVP, Chief Commercial Officer		2015-06-25 16:28:0571,283
0		71,283Form 4
METCALF BRIAN W
Chief Drug Discovery Scientist		2011-04-13 16:09:0166,504
0		66,504Form 4
Denton Sheila A.
EVP & General Counsel		2023-10-04 15:08:2355,249
0		55,249Form 4
Iyengar Vijay K
EVP, GMAPPS		2024-02-16 12:48:3050,789
0		50,789Form 4
ARIKO BARRY A
Director		2015-03-13 16:28:0245,834
0		45,834Form 4
Dickinson Jonathan Elliott
EVP, General Manager, Europe		2024-01-24 14:14:4344,380
0		44,380Form 4
HURLEY SCOTT W
VP/Corp Controller & Treasurer		2005-01-27 12:58:5940,000
0		40,000Form 4
Huber Reid M
EVP, Chief Scientific Officer		2018-07-18 16:28:2634,571
0		34,571Form 4
FBB Associates
Director
10% Owner		2012-06-18 17:33:5633,410
0		33,410Form 3
Trotta Matteo
EVP, GM, Dermatology US		2024-03-27 13:04:3229,696
0		29,696Form 4
Tray Thomas
Principal Accounting Officer		2024-01-19 17:30:3926,945
0		26,945Form 4
BIENAIME JEAN JACQUES
Director		2023-06-16 16:00:1326,787
0		26,787Form 4
FOUSE JACQUALYN A
Director		2023-06-16 16:00:2925,272
0		25,272Form 4
SCHRECK PATRICIA A
EVP, General Counsel		2011-05-11 16:17:5322,276
0		22,276Form 4
CAGNONI PABLO J
President, R&D		2024-01-22 13:04:3621,843
0		21,843Form 4
Siegel Eric H.
EVP, General Counsel		2017-09-15 16:28:3321,053
0		21,053Form 4
CRAVES FRED B
Director		2005-06-03 09:43:5120,000
0		20,000Form 4
Emmens Matthew
Director		2008-05-22 16:32:4320,000
0		20,000Form 4
NIBLACK JOHN F
Director		2011-05-23 16:38:4120,000
0		20,000Form 4
Levy Richard S
EVP, Chief Drug Dev Officer		2016-01-08 16:37:5619,802
0		19,802Form 4
High Katherine A
Director		2023-06-16 16:00:3419,287
0		19,287Form 4
DIXON WENDY L
Director		2022-04-04 16:00:3217,768
0		17,768Form 4
BRAWLEY OTIS W
Director		2023-06-16 16:00:3417,198
0		17,198Form 4
Clancy Paul J
Director		2024-04-02 12:12:4015,785
0		15,785Form 4
Chardonnet Laurent
Vice President and Treasurer		2015-04-01 16:27:3815,129
0		15,129Form 4
FBB2 LLC
Director
10% Owner		2012-06-18 17:35:4815,110
0		15,110Form 3
Friedman Steven M.
EVP, Biology & Preclinical Dev		2010-05-20 16:11:5515,000
0		15,000Form 4
Schaffert Susanne
Director		2023-06-16 16:00:2714,936
0		14,936Form 4
HARRIGAN EDMUND
Director		2024-04-02 12:12:1713,115
0		13,115Form 4
GRYSKA DAVID W
Executive Vice President, CFO		2018-07-18 16:12:4110,235
0		10,235Form 4
Trower Paul
Principal Accounting Officer		2022-01-21 16:37:503250
0		3250Form 4
PLATINUM ASSET MANAGEMENT LTD
10% Owner		2009-02-10 18:56:090
0		0Form 13G
DAMIAL FOUNDATION INC
10% Owner		2004-02-13 19:51:280
0		0Form 4
TISCH BONNIE J
10% Owner		2004-01-16 16:57:590
0		0Form 4